Sotera Health Company (SHC) Stock Price, Quote & News

Company Profile

Sotera Health Company provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for the medical device, pharmaceutical, and food safety and adv...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 440 262 1410

Website: soterahealth.com

Address:

9100 South Hills Blvd, Suite 300, Broadview Heights, United States

StagflationSage Dec. 25 at 4:30 PM

$SHC What matters next is the company’s ability to build a predictable delivery rhythm. Execution gaps should narrow meaningfully over coming quarters. Unexpected delays could weigh disproportionately on sentiment. The next phase will be defined less by vision and more by delivery.

0 · Reply

PrivateProfiteersAnalyst Dec. 25 at 3:14 PM

$SHC Actionable Trade Alert: Market Context: $SHC is currently trading at $17.7, showing strong momentum with an RSI of 80.98, indicating overbought conditions. The stock is above its 30-day MA of 16.69 and 50-day MA of 16.57, suggesting bullish sentiment. However, the high RSI signals a potential pullback. Directional Bias: Given the RSI and the recent 60-day high of $17.83, a short-term bullish outlook remains, but caution is advised due to overbought conditions. Trade Plan: - Suggested Entry: $17.7 - Stop Loss: $16.90 (below recent support) - Take Profit Targets: 1. $18.00 (1.7% gain) 2. $18.50 (4.4% gain) 3. $20.00 (13.9% gain, 17% ROI) Monitor price action closely; if it breaks above $17.83, adjust targets accordingly. For further insights and updates, visit https://privateprofiteers.com. https://privateprofiteers.com

0 · Reply

PrivateProfiteersAnalyst Dec. 19 at 5:10 PM

$SHC Trade Alert: Market Context: $SHC is currently trading at $17.11, showing potential for upward movement as it approaches the 60D high of $17.78. The RSI at 41.47 indicates the stock is not overbought, suggesting room for growth. The moving averages (MA30 at 16.49 and MA50 at 16.43) are below the current price, indicating bullish momentum. Directional Bias: With the RSI below 50 and close to the lower end of the 60D range, there is a potential for a rebound towards the recent high, supported by the upward trend in MAs. Trade Plan: - Suggested Entry: $17.15 - Stop Loss: $16.80 (2% below entry) - Take Profit Targets: 1. TP1: $17.50 (2% gain) 2. TP2: $17.70 (3.22% gain) 3. TP3: $20.00 (16.88% gain) This trade plan offers a solid risk-reward ratio with a potential ROI of over 17% on TP3. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com

0 · Reply

JarvisFlow Dec. 18 at 12:10 PM

William Blair has updated their rating for Sotera Health ( $SHC ) to Outperform.

0 · Reply

PrivateProfiteersAnalyst Dec. 17 at 3:55 AM

$SHC Actionable Trade Alert: Market Context: $SHC is currently trading at $16.7, showing potential for a rebound given the oversold RSI at 32.09. The stock is positioned above its 30-day moving average (MA30) of 16.43 and MA50 of 16.4, suggesting a bullish trend may emerge. Directional Bias: The RSI indicates oversold conditions, which often precedes upward price movements. Additionally, the recent high of $17.78 provides a resistance level to target, while the 60D low of $14.96 establishes a solid support base. Trade Plan: - Suggested Entry: $16.70 - Stop Loss: $16.00 (4.2% below entry) - Take Profit Targets: 1. $17.00 (1.8% gain) 2. $17.50 (4.8% gain) 3. $19.50 (16.8% gain) With a strategic entry and defined targets, this plan aims for a minimum of 17% ROI at the third target. Monitor the trade closely for volatility, given the ATR of 0.36. https://privateprofiteers.com

0 · Reply

PrivateProfiteersAnalyst Dec. 15 at 7:29 AM

$SHC Trade Alert: Market Context: $SHC is currently trading at $16.83, showing a bullish sentiment as indicated by the RSI of 58.99, which suggests upward momentum without being overbought. The price is above the 30-day MA (16.42) and 50-day MA (16.37), reinforcing a positive trend. Directional Bias: Given the proximity to the 60-day high of $17.78 and the current price positioning, there is a clear upward bias. The ATR of 0.4 indicates reasonable volatility for potential gains. Trade Plan: - Suggested Entry: $16.85 - Stop Loss: $16.40 (below recent support levels) - Take Profit Targets: 1. $17.20 (2% gain) 2. $17.50 (3.96% gain) 3. $19.67 (16.5% gain) This plan provides a solid risk-reward ratio, with the third target offering over 17% ROI. Monitor the trade closely for any changes in market conditions. https://privateprofiteers.com

0 · Reply

megan_hughes09 Dec. 12 at 5:57 PM

$SHC Mainz Biomed is basing right where traders love to buy risk, $1.00 figure support + VWAP ~1.027 overhead, and the “why” is simple numbers like 1,926,425 global CRC cases and a test profile citing 82% advanced adenomas

0 · Reply

PrivateProfiteersAnalyst Dec. 12 at 12:22 AM

$SHC Actionable Trade Alert: Market Context: $SHC is currently trading at $16.99, nearing its 60D high of $17.78. The RSI of 67.96 indicates that the stock is approaching overbought territory, suggesting potential for a pullback or consolidation. However, the strong positioning above the MA30 (16.41) and MA50 (16.35) supports bullish momentum. Directional Bias: The proximity to the 60D high combined with the positive MA trends indicates a bullish sentiment. The stock has shown resilience, making a breakout above $17.78 plausible. Trade Plan: - Suggested Entry: $17.00 (breakout entry) - Stop Loss: $16.40 (below MA30) - Take Profit Targets: 1. $17.50 (3% gain) 2. $18.00 (5.9% gain) 3. $19.00 (11.8% gain, 17% ROI from entry) Monitor price action closely; adjust stop loss to protect gains as targets are hit. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com

0 · Reply

Lunar_Rune_451 Dec. 11 at 7:43 PM

$SHC Mainz Biomed looked like a straight downtrend from 2.00, but now it’s stopped making new lows, that’s exactly when I start planning for the first real reversal leg 📉➡️📈

0 · Reply

PrivateProfiteersAnalyst Dec. 10 at 4:25 AM

$SHC Trade Alert: Market Context: $SHC is currently trading at $16.71 with a strong RSI of 70.44, indicating overbought conditions. However, the stock is above its 30-day (MA30) and 50-day (MA50) moving averages, suggesting a bullish trend. The 60-day high of $17.78 offers a potential resistance level. Directional Bias: Given the RSI and proximity to the 60D high, we anticipate a short-term pullback before a potential breakout. Trade Plan: - Suggested Entry: $16.50 (anticipating a slight dip) - Stop Loss: $15.90 (to limit risk) - Take Profit Targets: 1. $17.00 (1.5% gain) 2. $17.50 (4.7% gain) 3. $19.00 (13.6% gain) Achieving the third target would yield a 17% ROI. Monitor the stock closely for volatility and adjust stop loss as needed. https://privateprofiteers.com

0 · Reply

Sotera Health Announces Secondary Offering of Common Stock

Nov 4, 2025, 2:26 PM EST - 7 weeks ago

Sotera Health Company (SHC) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 7:00 AM EST - 7 weeks ago

Sotera Health Reports Strong Third-Quarter and Year-to-Date 2025 Results

Oct 21, 2025, 5:13 PM EDT - 2 months ago

Sotera Health Announces Third-Quarter 2025 Earnings Release Date

Aug 8, 2025, 12:51 PM EDT - 4 months ago

Sotera Health Company (SHC) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 7:30 AM EDT - 4 months ago

Sotera Health Reports Strong Second-Quarter and First-Half 2025 Results

Jul 28, 2025, 7:38 AM EDT - 5 months ago

Sotera Health Announces Second-Quarter 2025 Earnings Release Date

Jul 21, 2025, 7:06 AM EDT - 5 months ago

Trends Shaping Qatar's Infection Control Market 2025-2034: Featuring Sidra Medicine, BD, Condair, Sotera Health, Olympus, 3M

May 2, 2025, 2:37 PM EDT - 8 months ago

Sotera Health Company (SHC) Q1 2025 Earnings Call Transcript

May 1, 2025, 7:38 AM EDT - 8 months ago

Sotera Health Reports First-Quarter 2025 Results

Apr 17, 2025, 5:16 PM EDT - 8 months ago

Sotera Health Announces First-Quarter 2025 Earnings Release Date

Apr 8, 2025, 12:34 PM EDT - 9 months ago

Sotera Health Has A Great Deleveraging Path Ahead

Mar 4, 2025, 7:00 AM EST - 10 months ago

Nelson Labs Launches Innovative Rapid Sterility Testing to Significantly Expedite Product Sterility Results

Feb 27, 2025, 2:15 PM EST - 10 months ago

Sotera Health Company (SHC) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 7:00 AM EST - 10 months ago

Sotera Health Reports Fourth-Quarter and Full-Year 2024 Results; Provides 2025 Outlook

Feb 18, 2025, 4:30 PM EST - 11 months ago

Sotera Health Announces Fourth-Quarter and Full-Year 2024 Earnings Release Date

Jan 14, 2025, 7:30 AM EST - 1 year ago

Sotera Health Chairman and CEO Presents at 43rd Annual J.P. Morgan Healthcare Conference

Jan 7, 2025, 4:30 PM EST - 1 year ago

Sotera Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 6, 2025, 4:30 PM EST - 1 year ago

Sotera Health Company Appoints Vincent K. Petrella as Lead Independent Director

Dec 18, 2024, 7:00 AM EST - 1 year ago

Firstlight Management Calls on the Board of Directors of Sotera Health Company to Launch Sale Process for Nelson Labs

Dec 4, 2024, 6:15 AM EST - 1 year ago

Top 3 Health Care Stocks That Could Blast Off In December

ELAN RVMD

Nov 20, 2024, 9:00 AM EST - 1 year ago

Sotera Health to Share Next Chapter of Growth at 2024 Investor Day

Nov 5, 2024, 5:04 PM EST - 1 year ago

Sotera Health Company (SHC) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 7:00 AM EST - 1 year ago

Sotera Health Reports Third-Quarter and Year-to-Date 2024 Results

Oct 22, 2024, 4:30 PM EDT - 1 year ago

Sotera Health Announces Dates for Third-Quarter 2024 Earnings Release and November 2024 Investor Day

Aug 5, 2024, 2:44 PM EDT - 1 year ago

Sotera Health Company (SHC) Q2 2024 Earnings Call Transcript

Aug 5, 2024, 7:00 AM EDT - 1 year ago

Sotera Health Reports Second-Quarter and First-Half 2024 Results

Aug 1, 2024, 7:00 AM EDT - 1 year ago

Sotera Health Appoints Christopher Simon to the Board of Directors

Jul 30, 2024, 9:45 AM EDT - 1 year ago

The Schall Law Firm Urges Sotera Health Company Investors With Losses Over $100,000 To Establish Communication

Jul 26, 2024, 4:30 PM EDT - 1 year ago

The Schall Law Firm Encourages Sotera Health Company Investors With Losses Over $100,000 To Establish Communication

Jul 22, 2024, 5:00 PM EDT - 1 year ago

Sotera Health Announces Second-Quarter 2024 Earnings Release Date

Jul 18, 2024, 5:45 PM EDT - 1 year ago

Investors Of Sotera Health Company With Losses Exceeding $100,000 Are Encouraged By The Schall Law Firm To Initiate Contact

Jul 17, 2024, 3:00 PM EDT - 1 year ago

Investors Of Sotera Health Company Who Have Experienced Losses Exceeding $100,000 Are Urged By The Schall Law Firm To Get In Touch

Jul 16, 2024, 3:00 PM EDT - 1 year ago

The Schall Law Firm Encourages Sotera Health Company Investors With Losses Surpassing $100,000 To Initiate Contact

Jul 15, 2024, 2:45 PM EDT - 1 year ago

Sotera Health Company Investors With Losses Exceeding $100,000 Are Urged By The Schall Law Firm To Establish Communication

Jul 13, 2024, 5:00 PM EDT - 1 year ago

Investors Of Sotera Health Company With Over $100,000 Losses Are Encouraged By The Schall Law Firm To Initiate Contact

Jul 12, 2024, 6:00 PM EDT - 1 year ago

Sotera Health Company Investors With Over $100,000 Losses Are Urged By The Schall Law Firm To Begin Communication

Jul 11, 2024, 2:15 PM EDT - 1 year ago

The Schall Law Firm Encourages Sotera Health Company Investors With Losses Over $100,000 To Initiate Contact

Jul 10, 2024, 2:00 PM EDT - 1 year ago

Investors Of Sotera Health Company With Losses Exceeding $100,000 Are Urged To Begin Communication By The Schall Law Firm

Jul 9, 2024, 2:30 PM EDT - 1 year ago

Investors Of Sotera Health Company With Losses Surpassing $100,000 Are Encouraged To Initiate Contact By The Schall Law Firm

Jul 8, 2024, 1:15 PM EDT - 1 year ago

Sotera Health Company Investors With Losses Exceeding $100,000 Are Urged To Start Communication By The Schall Law Firm

Jul 7, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Appeals To Sotera Health Company Investors With Losses Above $100,000 To Commence Contact

Jul 6, 2024, 11:00 AM EDT - 1 year ago

Investors Of Sotera Health Company With Losses Over $100,000 Are Prompted By The Schall Law Firm To Start Communication

Jul 5, 2024, 3:00 PM EDT - 1 year ago

The Schall Law Firm Encourages Sotera Health Company Investors With Losses Surpassing $100,000 To Begin Interaction

Jul 3, 2024, 12:15 PM EDT - 1 year ago

The Schall Law Firm Urges Investors Of Sotera Health Company With Losses Exceeding $100,000 To Initiate Communication

Jul 2, 2024, 2:45 PM EDT - 1 year ago

The Schall Law Firm Encourages Sotera Health Company Investors With Losses Over $100,000 To Begin Contact

Jun 28, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Urges Investors In Sotera Health Company With Losses Exceeding $100,000 To Initiate Contact

Jun 26, 2024, 3:15 PM EDT - 1 year ago

The Schall Law Firm Encourages Investors In Sotera Health Company With Losses Surpassing $100,000 To Establish Communication

Jun 23, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Urges Investors In Sotera Health Company (NASDAQ:SHC) Experiencing Losses Exceeding $100,000 To Initiate Contact

Jun 22, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Encourages Investors In Sotera Health Company (NASDAQ:SHC) With Losses Over $100,000 To Establish Communication

StagflationSage Dec. 25 at 4:30 PM

0 · Reply

PrivateProfiteersAnalyst Dec. 25 at 3:14 PM

0 · Reply

PrivateProfiteersAnalyst Dec. 19 at 5:10 PM

0 · Reply

JarvisFlow Dec. 18 at 12:10 PM

William Blair has updated their rating for Sotera Health ( $SHC ) to Outperform.

0 · Reply

PrivateProfiteersAnalyst Dec. 17 at 3:55 AM

0 · Reply

PrivateProfiteersAnalyst Dec. 15 at 7:29 AM

0 · Reply

megan_hughes09 Dec. 12 at 5:57 PM

0 · Reply

PrivateProfiteersAnalyst Dec. 12 at 12:22 AM

0 · Reply

Lunar_Rune_451 Dec. 11 at 7:43 PM

$SHC Mainz Biomed looked like a straight downtrend from 2.00, but now it’s stopped making new lows, that’s exactly when I start planning for the first real reversal leg 📉➡️📈

0 · Reply

PrivateProfiteersAnalyst Dec. 10 at 4:25 AM

0 · Reply

BillionerOfKing Dec. 9 at 7:33 PM

$SHC Current Stock Price: $16.69 Contracts to trade: $17.5 SHC Dec 19 2025 Call Entry: $0.45 Exit: $0.58 ROI: 29% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

PrivateProfiteersAnalyst Dec. 9 at 12:14 AM

Actionable Trade Alert for $SHC: Market Context: $SHC is currently trading at $16.66, showing strong momentum with an RSI of 70.11, indicating overbought conditions. However, the price is above both the 30-day MA (16.39) and the 50-day MA (16.30), suggesting bullish sentiment in the short to medium term. The 60-day high is at $17.78, which presents a potential resistance level. Directional Bias: Despite the overbought RSI, the price is trending above key moving averages, indicating a bullish bias. The recent high-low range (60D High: $17.78, Low: $14.96) suggests potential for upward movement. Trade Plan: - Suggested Entry: $16.70 (slightly above last close to confirm upward momentum) - Stop Loss: $16.20 (below recent support) - Take Profit Targets: 1. $17.00 (1.80% gain) 2. $17.50 (4.80% gain) 3. $19.50 (17.00% gain) This trade plan aims for a minimum of 17% ROI on the third target. https://privateprofiteers.com

0 · Reply

PrivateProfiteersAnalyst Dec. 6 at 3:13 AM

$SHC Actionable Trade Alert: Market Context: $SHC is currently trading at $16.56, showing a solid position within its recent range. The RSI at 56.96 indicates a neutral to slightly bullish sentiment, suggesting potential for upward movement. The stock is above its 30-day moving average (MA30) of $16.4 and 50-day moving average (MA50) of $16.26, indicating a bullish trend. Directional Bias: The price is closer to the 60-day high of $17.78, providing room for upside potential. The ATR of 0.51 suggests moderate volatility, suitable for trading. Trade Plan: - Suggested Entry: $16.60 - Stop Loss: $15.90 (4.2% below entry) - Take Profit Targets: 1. $17.00 (2.4% gain) 2. $17.40 (4.8% gain) 3. $19.40 (17% gain) This plan offers a favorable risk-reward ratio with a potential for over 17% ROI at the third target. Monitor closely and adjust as needed. https://privateprofiteers.com

0 · Reply

PrivateProfiteersAnalyst Dec. 5 at 10:48 PM

0 · Reply

MichaelVillegas378 Dec. 5 at 3:13 PM

$SHC operates in hospitality and lodging — markets sensitive to economic cycles but reliant on efficient operations. AERT’s automation-driven delivery offers scalable improvements for firms managing large data or reservation systems. https://www.nasdaq.com/press-release/aeries-technologys-consulting-led-automation-practice-delivers-measurable-impact-0

0 · Reply

BEATOFtheMARKET Dec. 2 at 2:34 PM

$SHAK $SHC $SHIP $SHLS $SHOP Undeniable Accuracy Cycle Trading Signal plugged into AI Lists 🔥

0 · Reply

BEATOFtheMARKET Nov. 23 at 5:33 PM

$SHAK $SHC $SHIP $SHLS $SHOP 🔥

0 · Reply

JarvisFlow Nov. 13 at 10:21 AM

BMO Capital updates rating for Sotera Health ( $SHC ) to Outperform, target set at 19.

0 · Reply

thebadfish843 Nov. 12 at 8:27 PM

$SHC 👀

0 · Reply

AStrokeOfLuck Nov. 6 at 10:42 PM

$SHC

0 · Reply

JarvisFlow Nov. 5 at 7:45 PM

JP Morgan has adjusted their stance on Sotera Health ( $SHC ), setting the rating to Neutral with a target price of 14 → 16.

0 · Reply

JarvisFlow Nov. 5 at 6:00 PM

Barclays has adjusted their stance on Sotera Health ( $SHC ), setting the rating to Overweight with a target price of 19 → 20.

0 · Reply

Market Cap	4.95B
Revenue (ttm)	1.10B
Net Income (ttm)	44.34M
EPS (ttm)	N/A
PE Ratio	23.67
Forward PE	23.04
Profit Margin	4.03%
Debt to Equity Ratio	3.89

Volume	1,147,200
Avg Vol	2,510,854
Day's Range	N/A - N/A
Shares Out	284.09M
Stochastic %K	90%
Beta	1.81
Analysts	Sell
Price Target	$18.93